Citations to this article


In broad terms, there are 3 types of cardiac hypertrophy: normal growth, growth induced by physical conditioning (i.e., physiologic hypertrophy), and growth induced by pathologic stimuli. Recent evidence suggests that normal and exercise-induced cardiac growth are regulated in large part by the growth hormone/IGF axis via signaling through the PI3K/Akt pathway. In contrast, pathological or reactive cardiac growth is triggered by autocrine and paracrine neurohormonal factors released during biomechanical stress that signal through the Gq/phospholipase C pathway, leading to an increase in cytosolic calcium and activation of PKC. Here we review recent developments in the area of these cardiotrophic kinases, highlighting the utility of animal models that are helping to identify molecular targets in the human condition.


Gerald W. Dorn II, Thomas Force


Total citations by year

Year: 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 Total
Citations: 7 17 27 18 33 33 34 37 24 32 10 272
Citation information

Citations to this article in year 2011 (33)

Title and authors Publication Year
Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy
ED Frohlich, A González, J Díez
Journal of Hypertension 2011
Tapping the brake on cardiac growth-endogenous repressors of hypertrophic signaling-
JJ Leenders, YM Pinto, EE Creemers
Journal of Molecular and Cellular Cardiology 2011
MicroRNA Involvement in Immune Activation During Heart Failure
M de Vrie, S Heymans, B Schroen
Cardiovascular Drugs and Therapy 2011
MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1L613V mutation
X Wu, J Simpson, JH Hong, KH Kim, NK Thavarajah, PH Backx, BG Neel, T Araki
Journal of Clinical Investigation 2011
Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome–associated PTPN11 mutation
TM Marin, K Keith, B Davies, DA Conner, P Guha, D Kalaitzidis, X Wu, J Lauriol, B Wang, M Bauer, R Bronson, KG Franchini, BG Neel, MI Kontaridis
Journal of Clinical Investigation 2011
Urocortin-induced cardiomyocytes hypertrophy is associated with regulation of the GSK-3β pathway
D Gruson, A Ginion, N Decroly, P Lause, JL Vanoverschelde, JM Ketelslegers, L Bertrand, JP Thissen
Heart and Vessels 2011
Is CaMKII a link between inflammation and hypertrophy in heart?
MV Singh, ME Anderson
Journal of Molecular Medicine 2011
Selective deletion of long but not short Cypher isoforms leads to late-onset dilated cardiomyopathy
H Cheng, M Zheng, AK Peter, K Kimura, X Li, K Ouyang, T Shen, L Cui, D Frank, ND Dalton, Y Gu, N Frey, KL Peterson, SM Evans, KU Knowlton, F Sheikh, J Chen
Human Molecular Genetics 2011
FGF23 induces left ventricular hypertrophy
C Faul, AP Amaral, B Oskouei, MC Hu, A Sloan, T Isakova, OM Gutiérrez, R Aguillon-Prada, J Lincoln, JM Hare, P Mundel, A Morales, J Scialla, M Fischer, EZ Soliman, J Chen, AS Go, SE Rosas, L Nessel, RR Townsend, HI Feldman, MS Sutton, A Ojo, C Gadegbeku, GS di Marco, S Reuter, D Kentrup, K Tiemann, M Brand, JA Hill, OW Moe, M Kuro-o, JW Kusek, MG Keane, M Wolf
Journal of Clinical Investigation 2011
Transcription coactivator Eya2 is a critical regulator of physiological hypertrophy
SH Lee, J Kim, JY Ryu, S Lee, DK Yang, D Jeong, J Kim, SH Lee, JM Kim, RJ Hajjar, WJ Park
Journal of Molecular and Cellular Cardiology 2011
Heart Failure: A Companion to Braunwald's Heart Disease
A Diwan, GW Dorn
Heart Failure: A Companion to Braunwald's Heart Disease 2011
Scaffold-Based Transplantation of Akt1 -Overexpressing Skeletal Myoblasts: Functional Regeneration Is Associated with Angiogenesis and Reduced Infarction Size
M Siepe, P Golsong, A Poppe, B Blumenthal, R Wattenwyl, C Heilmann, K Förster, C Schlensak, F Beyersdorf
Tissue Engineering Part A 2011
Endogenous Muscle Atrophy F-box Mediates Pressure Overload-Induced Cardiac Hypertrophy through Regulation of NF-κB
S Usui, Y Maejima, J Pain, C Hong, J Cho, JY Park, D Zablocki, B Tian, DJ Glass, J Sadoshima
Circulation research 2011
Activating Transcription Factor 3 Deficiency Promotes Cardiac Hypertrophy, Dysfunction, and Fibrosis Induced by Pressure Overload
H Zhou, DF Shen, ZY Bian, J Zong, W Deng, Y Zhang, YY Guo, H Li, QZ Tang
PloS one 2011
G protein-dependent and –independent signaling pathways and their impact on cardiac function
DG Tilley
Circulation research 2011
Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure
T Aoyagi, T Matsui
Current pharmaceutical design 2011
Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling molecules
N Yamaguchi, A Chakraborty, DA Pasek, JD Molkentin, G Meissner
AJP Heart and Circulatory Physiology 2011
Gαq Signal in Osteoblasts Is Inhibitory to the Osteoanabolic Action of Parathyroid Hormone*
N Ogata, Y Shinoda, N Wettschureck, S Offermanns, S Takeda, K Nakamura, GV Segre, U Chung, H Kawaguchi
The Journal of biological chemistry 2011
Cardiac Z-disc Signaling Network*
D Frank, N Frey
The Journal of biological chemistry 2011
Protein Kinase Cα as a Heart Failure Therapeutic Target
Q Liu, JD Molkentin
Journal of Molecular and Cellular Cardiology 2011
Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size
M Xin, Y Kim, LB Sutherland, X Qi, J McAnally, RJ Schwartz, JA Richardson, R Bassel-Duby, EN Olson
Science signaling 2011
Cardiac Tissue-Restricted Deletion of Plakoglobin Results in Progressive Cardiomyopathy and Activation of β-Catenin Signaling▿ †
J Li, D Swope, N Raess, L Cheng, EJ Muller, GL Radice
Molecular and cellular biology 2011
Genomics and genetics in the biology of adaptation to exercise
C Bouchard, T Rankinen, JA Timmons
Comprehensive Physiology 2011
Heart-Healthy Hypertrophy
CM Trivedi, JA Epstein
Cell Metabolism 2011
Expression patterns of imprinted gene Inpp5f-v3 during mouse brain development
C Yan, H Hongjuan, X Yanjiang, H Zhengbin, L Kai, Z Fengwei, H Jing, W Qiong
Journal Of Molecular Histology 2011